Tom Hennigan
Analyst · KBW. Your line is open
Thank you, Taylor. So now, I begin with a review of our first quarter earnings then I will provide further detail on the portfolio and our balance sheet positioning. As Linda previewed, we had another stable quarter on the earnings front. Total investment income for the first quarter was $41 million, that’s down from $44 million in the prior quarter primarily due to two main factors: first, a full quarter impact of lower average loan balance following the closing of our second JV in November; and second, lower OID accretion and prepayment fees due to lower loan repayments in the first quarter. This was partially offset by an increase in total dividend income from the two JVs, which increased due to full quarter impact from MMCF 2. Total expenses were $20 million in the quarter, down from $22 million last quarter. The largest component of the decrease was lower credit facility fees. The result was net investment income for the quarter of $0.36 per common share, or $20 million, right in line with guidance we provided during the last quarter’s earnings call. On May 3, our Board of Directors declared the dividends for the second quarter of 2021 at a total level of $0.36 per share. That comprises the $0.32 regular dividend plus the $0.04 supplemental, which is payable to shareholders of record as of the close of business on June 30. Similar to last quarter, as we look forward to the rest of 2021, we remain very confident in our ability to comfortably deliver the $0.32 regular dividend, but continue the sizable supplemental dividends. In line with the $0.04 to $0.05 we have been paying the last few quarters. Moving on to the performance of our two JVs, total dividend income was $7.5 million, up from $6.5 million last quarter. The increase was due to a full quarter impact of MMCF 2. On a combined basis, our dividend yield in the JVs was about 10%, in line with the prior quarter. Total assets at the JVs were down from $1.3 billion to $1.2 billion due to another wave of repayments that occurred at MMCF 1s later in the quarter. However, we have had positive momentum with new originations for that vehicle early in the second quarter. So going forward, we expect stable aggregate assets yield and dividend generation from the two JVs similar to the first quarter’s results. On valuations, our total aggregate realized and unrealized net gain was $15 million for the quarter, the fourth consecutive quarter of positive performance following the drop in March of 2020. Similar to the last three quarters, we saw valuations increase based on the continued rebound in market yields, plus improving fundamental credits. Using the same bucket that’s outlined in prior quarters, we again saw improvement across the board. First, performing lower COVID impacted borrowers plus our equity investments in the JVs, which accounts for combined 70% of the portfolio increased in value about $4 million compared to 12/31. Second, the assets that have been underperforming pre-pandemic, so much of COVID exposure were up $5 million, marking the fourth consecutive quarter of stability for improvements for this group. The final category is the moderate to heavier COVID impacted names. We continue to see a rebound in actual results and improvement in recovery prospects for these investments. Collectively, they also experienced the net $5 million increase in value. Given we are still in the early days for a sustained recovery for some of these borrowers, we continue to be appropriately conservative in our assessment of these credits. I will turn next to the portfolio and related activity. We continue to see overall stability and improvement across the book. Total non-accruals were flat at 3.3 based on fair value. And as we sit here today, we don’t see any additional loans at risk of non-accrual. The total fair value of transactions risk rated 3% to 5%, indicating some level of downgrade since we made the original investment is down again this quarter by about $33 million in the aggregate. Total M&A activity slowed down meaningfully in the first quarter, as we expected. We have two material amendments that closed for borrowers specifically impacted by COVID. Important point to note is that in exchange for covenant relief, sponsors injected significant incremental dollars to support the liquidity needs of each business. I will finish with a review of our financing facilities and liquidity. We continue to be very well positioned with the right size of our balance sheet. That said, we are always exploring various alternatives in both the private and public markets, particularly given the current issue of friendly financing environment. Regarding 03/31 results, statutory leverage was stable at about 1.2x, more net financial leverage, which as soon as the preferred is converted into this metric we used to manage the business for the game right around one turn of leverage. So, we are sitting close to the lower end of our target range of 1.0x to 1.4x, giving us flexibility to invest prudently in new attractive opportunities. And regarding the preferred equity issuance for May 2020, our stock continues to trade well above the conversion price. But as we previously noted, this instrument remains a long-term investment by Carlyle and BDC. So, there currently is no intention to convert. With that, back over to Linda for some closing remarks.